BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35268099)

  • 1. The Effect of Oral Probiotics (Streptococcus Salivarius k12) on the Salivary Level of Secretory Immunoglobulin A, Salivation Rate, and Oral Biofilm: A Pilot Randomized Clinical Trial.
    Babina K; Salikhova D; Polyakova M; Svitich O; Samoylikov R; Ahmad El-Abed S; Zaytsev A; Novozhilova N
    Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Strain Probiotic Supplementation with a Product Containing Human-Native
    Cernioglo K; Kalanetra KM; Meier A; Lewis ZT; Underwood MA; Mills DA; Smilowitz JT
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959944
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigingivitis and Antiplaque Effects of Oral Probiotic Containing the
    Babina K; Salikhova D; Doroshina V; Makeeva I; Zaytsev A; Uvarichev M; Polyakova M; Novozhilova N
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of
    Bertuccioli A; Gervasi M; Annibalini G; Binato B; Perroni F; Rocchi MBL; Sisti D; Amatori S
    Front Immunol; 2023; 14():1129060. PubMed ID: 36936914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
    Laws GA; Harold LK; Tagg JR; Hale JDF
    Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-centre investigator-blinded randomised parallel group clinical trial to investigate the effect of probiotic strains
    Kaklamanos EG; Nassar R; Kalfas S; Al Halabi M; Kowash M; Hannawi H; Hussein I; Salami A; Hassan A; Senok AC
    BMJ Open; 2019 Sep; 9(9):e030638. PubMed ID: 31501124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Streptococcus salivarius K12 on Halitosis: a Double-Blind, Randomized, Placebo-Controlled Trial.
    He L; Yang H; Chen Z; Ouyang X
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1321-1329. PubMed ID: 32227309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
    Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
    Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
    Sarlin S; Tejesvi MV; Turunen J; Vänni P; Pokka T; Renko M; Tapiainen T
    Pediatr Infect Dis J; 2021 May; 40(5):394-402. PubMed ID: 33298762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.
    Laws GL; Hale JDF; Kemp RA
    Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1521-1529. PubMed ID: 34282568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus salivarius Probiotics to Prevent Acute Otitis Media in Children: A Randomized Clinical Trial.
    Sarlin S; Koskela U; Honkila M; Tähtinen PA; Pokka T; Renko M; Tapiainen T
    JAMA Netw Open; 2023 Nov; 6(11):e2340608. PubMed ID: 37917062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial.
    Burton JP; Drummond BK; Chilcott CN; Tagg JR; Thomson WM; Hale JDF; Wescombe PA
    J Med Microbiol; 2013 Jun; 62(Pt 6):875-884. PubMed ID: 23449874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised, double-blind, placebo-controlled trial of oral probiotic Streptococcus salivarius M18 on head and neck cancer patients post-radiotherapy: a pilot study.
    Vesty A; Gear K; Boutell S; Taylor MW; Douglas RG; Biswas K
    Sci Rep; 2020 Aug; 10(1):13201. PubMed ID: 32764634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Clinical Trial of Oral Probiotic
    Salim HP; Mallikarjun SB; Raju S; Surendranath AR
    Int J Clin Pediatr Dent; 2023; 16(2):259-263. PubMed ID: 37519958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Streptococcus salivarius K12 with nystatin on oral candidiasis-RCT.
    Hu L; Mao Q; Zhou P; Lv X; Hua H; Yan Z
    Oral Dis; 2019 Sep; 25(6):1573-1580. PubMed ID: 31177581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study.
    Burton JP; Cowley S; Simon RR; McKinney J; Wescombe PA; Tagg JR
    Food Chem Toxicol; 2011 Sep; 49(9):2356-64. PubMed ID: 21722694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety assessment of
    Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
    Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotic
    Wang Y; Li J; Zhang H; Zheng X; Wang J; Jia X; Peng X; Xie Q; Zou J; Zheng L; Li J; Zhou X; Xu X
    Front Immunol; 2021; 12():684824. PubMed ID: 34149727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
    Park JA; Lee GR; Lee JY; Jin BH
    Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topic Application of the Probiotic
    Ferrer MD; López-López A; Nicolescu T; Perez-Vilaplana S; Boix-Amorós A; Dzidic M; Garcia S; Artacho A; Llena C; Mira A
    Front Cell Infect Microbiol; 2020; 10():465. PubMed ID: 32984080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.